ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.

Lei Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.